Wellness & Consumer Health Advisory
Regulatory strategy, product compliance, and market entry advisory for consumer wellness, nutraceutical, and functional health brands navigating complex multi-jurisdiction environments.
Navigating the Global Wellness Regulatory Landscape
The global wellness market presents significant commercial opportunity for innovative consumer health brands, but is characterised by fragmented regulatory frameworks that vary materially across the EU, GCC, ASEAN, and North American jurisdictions.
Innekto Incorporated provides wellness companies with comprehensive regulatory strategy spanning product classification, claims substantiation, novel ingredient dossiers, and multi-jurisdiction registration programmes. Our advisors have navigated EU Novel Food submissions, Singapore HSA notifications, GCC product registrations, and US dietary supplement regulatory frameworks.
Beyond regulatory, we support clients with market positioning strategy, distribution channel selection, competitive benchmarking, and commercial launch planning in each target market.
Wellness Advisory Services
Product classification analysis and strategy to determine the optimal regulatory pathway (food supplement, novel food, functional food, medical food) across target markets.
Preparation of regulatory submission dossiers including safety data, literature reviews, manufacturing information, and specification documentation.
Review and substantiation strategy for health claims, structure-function claims, and nutritional claims across applicable jurisdiction frameworks.
Market-by-market entry strategy covering regulatory timeline, partner identification, distribution structure, and launch sequencing.
Labelling review and mandatory disclosure design across all target markets, incorporating language requirements, font regulations, and format rules.
Post-registration compliance monitoring, regulatory change tracking, and annual reporting support for established market positions.
Representative Wellness Engagements
US Market Expansion Strategy for Nutraceutical and Cosmetic Portfolio
A GCC-based wellness and personal care company sought to enter the US market with an established portfolio of nutraceutical supplements and cosmetic products. The engagement presented layered regulatory complexity: several products occupied classification grey areas between cosmetics and drug claims, dietary supplement label claims carried DSHEA risk, and the client lacked internal US regulatory infrastructure to manage simultaneous FDA and FTC compliance obligations. A prior entry attempt without a structured regulatory framework had stalled commercial negotiations and undermined distributor confidence.
Innekto Incorporated conducted a product-by-product regulatory classification analysis across the portfolio, applying FDA cosmetic, OTC drug, and dietary supplement regulatory frameworks. Products were stratified by risk profile and commercial priority, with each line assigned a defined classification, compliant label claim strategy, and US market entry pathway. A compliance framework was designed covering ingredient review, required testing, labelling specifications under 21 CFR, and applicable facility registration obligations. Market entry channels were assessed across retail, direct-to-consumer, and B2B distribution, with recommendations informed by regulatory constraints. A phased expansion roadmap sequenced product launches to manage regulatory risk and capital deployment.
The client achieved regulatory clarity across the full product portfolio. Each line was assigned a defensible classification, compliant label claims, and a defined US entry pathway. The phased roadmap enabled immediate launch of the priority product cohort and provided a scalable framework for the remainder of the portfolio. The engagement restored distributor confidence and re-opened commercial negotiations on a compliance-ready basis.
Discuss a Wellness Advisory Mandate
Contact our team to discuss regulatory and market entry strategy for your wellness products.
The information presented on this page is intended for institutional counterparties and professional investors only. All references to target returns, yield strategies, and projected outcomes represent forward-looking estimates subject to material market, credit, liquidity, and operational risks. Past performance is not indicative of future results. Nothing herein constitutes an offer to buy or sell securities or investment products.